3D Systems Corporation
3D Systems Corporation sells 3D printing and digital manufacturing solutions built around printers for plastics and metals, proprietary materials, software, and services. The company organizes its business around two vertical-focused segments—Healthcare Solutions (e.g., dental and medical devices) and Industrial Solutions (e.g., aerospace, defense, transportation and general manufacturing). It supports customers with an end-to-end workflow that spans design, application engineering, production validation, and ongoing maintenance. In 2025 the company simplified its software portfolio through divestitures, including the sale of Geomagic and the sale of 3DXpert and Oqton, sharpening focus on its core printing/materials/services ecosystem.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueHardware platforms sold into healthcare and industrial production and prototyping workflows.
Primarily proprietary consumables plus complementary third-party materials sold for recurring use on installed printers.
Service contracts, field support, applications engineering, and advanced manufacturing services to help customers adopt and scale AM.
Software licenses, software maintenance, and SaaS subscriptions supporting the digital workflow (reduced after 2025 divestitures).
Peripheral hardware used for 3D data capture and interaction in design-to-manufacturing workflows.
Products
Reported · share of revenue- Products57.7 %
- Services42.3 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
3D Systems sells to both large enterprises and small-to-mid-sized businesses that need additive manufacturing capability, with demand concentrated in regulated healthcare and high-spec industrial applications. In Healthcare Solutions, buyers include dental labs and device manufacturers that value repeatable workflows, validated materials, and the ability to produce customized parts. In Industrial Solutions, aerospace/defense and transportation manufacturers use the company’s printers, materials, and engineering support to reduce lead times, consolidate parts, and enable complex geometries. The company sells through a mix of direct sales, channel partners, and distributors, and it uses Customer Innovation Centers and advanced manufacturing facilities to help customers validate applications before scaling in-house. Customer concentration exists in Healthcare, where two customers represented 12.2% and 11.4% of 2025 revenue.
Buy printers, proprietary materials, and services to produce customized dental/medical parts and support regulated workflows.
Adopt metal/plastic additive manufacturing for complex geometries, part consolidation, and supply-chain resilience; often require engineering support.
Use additive manufacturing for prototyping, tooling, and selective production parts to improve lead times and design flexibility.
Purchase systems, materials, and maintenance to provide printing services to multiple end-markets and manage utilization economics.
Buy systems and materials for R&D, training, and early-stage applications such as personalized health services and regenerative medicine.
Strategy
The company’s strategy centers on accelerating customer adoption of additive manufacturing in production environments by offering a full stack of hardware, materials, software, and services. A key lever is using applications engineering, Customer Innovation Centers, and advanced manufacturing services to help customers validate parts and ramp volumes before transitioning production in-house. The business also emphasizes proprietary materials and an installed-base service model to increase recurring revenue and customer switching costs. Portfolio actions in 2025, including divesting Geomagic and selling 3DXpert and Oqton, indicate a focus on simplifying the software footprint and prioritizing core solutions tied to printers, materials, and services.
Production use cases expand system pull-through and recurring materials/services demand.
Validation reduces adoption friction and creates a pathway to equipment and materials sales.
Divestitures reduce complexity and concentrate resources on printers, materials, and services.
Geography
3D Systems operates globally across the Americas, EMEA, and APAC, using a mix of direct sales, channel partners, and distributors to reach customers. Product design and application development are centered in the U.S. and Europe, aligning engineering resources with major end-markets and regulated healthcare needs. Manufacturing for 3D printer hardware is located in Rock Hill, South Carolina; Colorado Springs, Colorado; and Riom, France, which supports regional supply and service responsiveness. Materials production is spread across Rock Hill (U.S.), Marly (Switzerland), and Soesterberg (Netherlands), supplemented by third-party blending arrangements. The company’s international footprint creates exposure to foreign currency movements and operational complexity across regions.
Risks
Demand for 3D printers can be volatile because systems are high-priced, have long sales cycles, and ship in low unit volumes, making quarterly revenue sensitive to order timing and mix. The company operates internationally, so foreign currency fluctuations and cross-border execution can affect reported results and operational continuity. Customer concentration is notable in Healthcare Solutions, where two customers accounted for a meaningful portion of annual revenue, increasing exposure to purchasing changes or pricing pressure. The business is also exposed to cybersecurity and IT infrastructure risks given reliance on connected systems and third-party vendors. Industry-wide risks include rapid technology change, qualification requirements in regulated end-markets, and supply-chain constraints for specialized components and materials.
- Cybersecurity incident or IT infrastructure failureImpact: HighLikelihood: Medium
Reliance on IT systems and third-party vendors creates exposure to evolving threats that could cause disruption, data loss, legal claims, and reputational harm.
Exposure: Global operations; third-party vendor dependencies; sensitive/proprietary data
- Customer concentration in Healthcare SolutionsImpact: HighLikelihood: Medium
Two healthcare customers represented 12.2% and 11.4% of 2025 revenue, so changes in their demand or sourcing could materially impact results.
Exposure: Healthcare segment revenue
- Order timing and mix volatility for high-priced printersImpact: MediumLikelihood: Medium
Long selling cycles and low unit volumes mean shipment timing shifts can materially affect period revenue and margins.
Exposure: Hardware revenue and quarterly comparability
Accounting
Judgemental itemsTiming depends on transfer of control for products and delivery of services; shipment concentration can swing quarterly revenue.
Impact: Affects period revenue, gross margin, and comparability across quarters
Goodwill is assigned to Healthcare and impairment depends on fair value estimates driven by forecasts, margins, and discount rates.
Impact: Potential non-cash impairment charges impacting operating income
Recoverability and fair value rely on projected cash flows and valuation assumptions that can change with market conditions.
Impact: Non-cash charges and asset write-downs
Similar listed companies
Publicly listed companies with a comparable business focus.
Velo3D, Inc.
VELO · Special Industry Machinery, NEC
Stratasys, Ltd
SSYS · Computer Peripheral Equipment, NEC
OSI Systems, Inc
OSIS · Semiconductors & Related Devices
Merit Medical Systems, Inc
MMSI · Surgical & Medical Instruments & Apparatus
Merit Medical Systems designs, manufactures, and markets proprietary medical devices used in interventional, diagnostic, and therapeutic procedures.
Cisco Systems, Inc
CSCO · Computer Communications Equipment
Cisco Systems designs and sells networking, security, collaboration, and observability technologies that help organizations connect users, devices, applications, and data across the Internet.
OrthoPediatrics Corp
KIDS · Surgical & Medical Instruments & Apparatus
Last updated: 24/09/2026